¼¼°èÀÇ PARP ÀúÇØÁ¦ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2033³â)
Global PARP Inhibitor Biomarkers Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
»óǰÄÚµå : 1672193
¸®¼­Ä¡»ç : Value Market Research
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 128 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,920 £Ü 5,671,000
PDF & Excel (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,730 £Ü 6,843,000
PDF & Excel (10-user License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,430 £Ü 10,750,000
PDF & Excel (Corporate User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ PARP ÀúÇØÁ¦ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå ±Ô¸ð´Â 2024³â 10¾ï 1,000¸¸ ´Þ·¯¿¡¼­ 2033³â¿¡´Â 22¾ï 3,000¸¸ ´Þ·¯·Î ¼ºÀåÇϸç, 2026-2033³âÀÇ ¿¹Ãø ±â°£ Áß 9.11%ÀÇ °ß°íÇÑ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

PARP ¾ïÁ¦Á¦ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀº ¾Ï À¯º´·ü Áõ°¡¿Í Ç¥ÀûÄ¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î Å©°Ô ¼ºÀåÇϰí ÀÖÀ¸¸ç, PARP ¾ïÁ¦Á¦´Â ƯÁ¤ À¯ÀüÀÚ º¯À̰¡ ÀÖ´Â ¾Ï, ƯÈ÷ À¯¹æ¾Ï°ú ³­¼Ò¾ÏÀÇ Ä¡·á¿¡ À¯¸ÁÇÑ ¾àÁ¦±ºÀÔ´Ï´Ù. ¾Ï »ý¹°Çп¡ ´ëÇÑ ÀÌÇØµµ°¡ ³ô¾ÆÁü¿¡ µû¶ó PARP ¾ïÁ¦Á¦¿¡ ´ëÇÑ ¹ÝÀÀÀ» ¿¹ÃøÇÒ ¼ö ÀÖ´Â ¹ÙÀÌ¿À¸¶Ä¿¸¦ È®ÀÎÇÏ°í °ËÁõÇÏ´Â °ÍÀº ¸ÂÃãÀÇ·á¿¡ ÀÖÀ¸¸ç, ¸Å¿ì Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù. ¿¬±¸ÀÚ ¹× ÀÓ»óÀǵéÀÌ Ä¡·á Àü·«À» ÃÖÀûÈ­Çϰí ȯÀÚ °á°ú¸¦ °³¼±Çϱâ À§ÇØ ³ë·ÂÇÔ¿¡ µû¶ó ÀÌ ½ÃÀåÀº È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ ¹ÙÀÌ¿À¸¶Ä¿ Ž»ö ±â¼úÀÇ ¹ßÀüÀº PARP ¾ïÁ¦Á¦ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀÇ ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Â÷¼¼´ë ½ÃÄö¼­, ¾×ü»ý°Ë ±â¼ú, »ý¹°Á¤º¸ÇÐ ÅøÀÇ °³¹ß·Î PARP ¾ïÁ¦Á¦ÀÇ È¿´É°ú °ü·ÃµÈ ¹ÙÀÌ¿À¸¶Ä¿¸¦ ½Äº°ÇÏ°í °ËÁõÇÏ´Â ´É·ÂÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ¹ÙÀÌ¿À¸¶Ä¿ °Ë»çÀÇ Á¤È®µµ¸¦ Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó, Ä¡·á ¹æÄ§À» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â µ¿¹Ý Áø´Ü ¾à¹°ÀÇ °³¹ßÀ» ÃËÁøÇÕ´Ï´Ù. »õ·Î¿î ¹ÙÀÌ¿À¸¶Ä¿¿Í ±× ÀÓ»óÀû Àû¿ë¿¡ ´ëÇÑ ¿¬±¸°¡ ÁøÇàµÊ¿¡ µû¶ó ¾Ï Ä¡·áÀÇ Á¤È®µµ°¡ Çâ»óµÉ °ÍÀ¸·Î ±â´ëµÇ¸ç, ½ÃÀåÀº ´õ¿í È®´ëµÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¶ÇÇÑ ¸ÂÃãÇü ÀÇ·á¿Í ȯÀÚ Áß½ÉÀÇ Á¢±Ù¹ýÀÌ °­Á¶µÇ¸é¼­ PARP ¾ïÁ¦Á¦ ¹ÙÀÌ¿À¸¶Ä¿¿¡ ´ëÇÑ Àü¸ÁÀº ´õ¿í ¹à¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÇ·áÁøµéÀÌ È¯ÀÚ °³°³ÀÎÀÇ Æ¯¼ºÀ» °í·ÁÇÑ ¸ÂÃãÇü Ä¡·á °èȹÀ» ¿ì¼±½ÃÇÏ´Â °æÇâÀÌ °­È­µÊ¿¡ µû¶ó Ä¡·á ÀÇ»ç°áÁ¤¿¡ µµ¿òÀ» ÁÙ ¼ö ÀÖ´Â ½Å·ÚÇÒ ¼ö ÀÖ´Â ¹ÙÀÌ¿À¸¶Ä¿¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ¹ÙÀÌ¿À¸¶Ä¿ Áß½ÉÀÇ Àü·«À» ÅëÇØ »õ·Î¿î Ä¡·áÀÇ È¿À²¼º°ú ¼º°ø·üÀ» Çâ»ó½Ãų ¼ö ÀÖ´Â ÀÓ»ó½ÃÇè ¹× ÀǾàǰ °³¹ß°ú ƯÈ÷ °ü·ÃÀÌ ÀÖÀ¸¸ç, PARP ¾ïÁ¦Á¦ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀÌ °è¼Ó ÁøÈ­ÇÏ´Â °¡¿îµ¥, ±â¼ú ¹ßÀü, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½É, È¿°úÀûÀÎ ¾Ï Ä¡·á¿¡ ´ëÇÑ ¿ä±¸°¡ °áÇÕÇÏ¿© ¹Ì·¡ÀÇ ±ËÀûÀ» Çü¼ºÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ °ÍÀÔ´Ï´Ù.À» Çü¼ºÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ °ÍÀÔ´Ï´Ù.

´ç»çÀÇ º¸°í¼­´Â °í°´¿¡°Ô ´Ù¾çÇÑ »ê¾÷ ¹× ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÌ°í ½Ç¿ëÀûÀÎ ÀλçÀÌÆ®¸¦ Á¦°øÇϱâ À§ÇØ ¼¼½ÉÇÑ ÁÖÀǸ¦ ±â¿ï¿© ÀÛ¼ºµÇ¾ú½À´Ï´Ù. °¢ º¸°í¼­´Â ½ÃÀå »óȲÀ» ¿ÏÀüÈ÷ ÀÌÇØÇϱâ À§ÇØ ¸î °¡Áö Áß¿äÇÑ ¿ä¼Ò¸¦ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä : Á¤ÀÇ, ºÐ·ù, »ê¾÷ ÇöȲ µî ½ÃÀå¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ¼Ò°³.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ : ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× °úÁ¦¸¦ »ó¼¼ÇÏ°Ô ºÐ¼®ÇÕ´Ï´Ù. ÀÌ ¼½¼Ç¿¡¼­´Â ±â¼ú ¹ßÀü, ±ÔÁ¦ º¯È­, »õ·Î¿î µ¿Çâ µîÀÇ ¿äÀÎÀ» °ËÅäÇÕ´Ï´Ù.

¼¼ºÐÈ­ ºÐ¼® : Á¦Ç° À¯Çü, ¾ÖÇø®ÄÉÀ̼Ç, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ª µîÀÇ ±âÁØ¿¡ µû¶ó ½ÃÀåÀ» ¸íÈ®ÇÑ ºÎ¹®À¸·Î ºÐ·ùÇÕ´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ °¢ ºÎ¹®ÀÇ ¼º°ú¿Í ÀáÀç·ÂÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

°æÀï ±¸µµ : ½ÃÀå Á¡À¯À², Á¦Ç° Æ÷Æ®Æú¸®¿À, Àü·«Àû ±¸»ó, À繫 ½ÇÀû µî ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ Æò°¡. ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇϰí ÀÖ´Â °æÀï ¿ªÇÐ ¹× ÁÖ¿ä Àü·«¿¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¿¹Ãø : °ú°Å µ¥ÀÌÅÍ¿Í ÇöÀç ½ÃÀå »óȲÀ» ¹ÙÅÁÀ¸·Î ÀÏÁ¤ ±â°£ Áß ½ÃÀå ±Ô¸ð¿Í ¼ºÀå Ãß¼¼¸¦ ¿¹ÃøÇÕ´Ï´Ù. ¿©±â¿¡´Â Á¤·®Àû ºÐ¼®°ú ¹Ì·¡ ½ÃÀå ±ËÀûÀ» º¸¿©ÁÖ´Â ±×·¡ÇÁ Ç¥½Ã°¡ Æ÷ÇԵ˴ϴÙ.

Áö¿ª ºÐ¼® : Áö¿ªº° ½ÃÀå ¼º°ú¸¦ Æò°¡Çϰí ÁÖ¿ä ½ÃÀå ¹× Áö¿ª µ¿ÇâÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. Áö¿ª ½ÃÀå ¿ªÇÐ ¹× ºñÁî´Ï½º ±âȸ¸¦ ÀÌÇØÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

»õ·Î¿î µ¿Çâ°ú ±âȸ : ÇöÀç ½ÃÀå µ¿Çâ°ú »õ·Î¿î ½ÃÀå µ¿Çâ, ±â¼ú Çõ½Å, ÀáÀçÀû ÅõÀÚ ´ë»ó ºÐ¾ß¸¦ ÆÄ¾ÇÇÕ´Ï´Ù. ¹Ì·¡ ½ÃÀå °³¹ß ¹× ¼ºÀå Àü¸Á¿¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå °³¿ä

Á¦3Àå PARP ÀúÇØÁ¦ ¹ÙÀÌ¿À¸¶Ä¿ »ê¾÷ ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ PARP ÀúÇØÁ¦ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå ºÐ¼® : Á¦Ç°º°

Á¦6Àå ¼¼°èÀÇ PARP ÀúÇØÁ¦ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå ºÐ¼® : ¼­ºñ½ºº°

Á¦7Àå ¼¼°èÀÇ PARP ÀúÇØÁ¦ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå ºÐ¼® : ¿ëµµº°

Á¦8Àå ¼¼°èÀÇ PARP ÀúÇØÁ¦ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦9Àå PARP ÀúÇØÁ¦ ¹ÙÀÌ¿À¸¶Ä¿ ±â¾÷ÀÇ °æÀï ±¸µµ

Á¦10Àå ±â¾÷ °³¿ä

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global PARP Inhibitor Biomarkers Market size is anticipated to grow from USD 1.01 Billion in 2024 to USD 2.23 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 9.11% during the forecast period of 2026 to 2033.

The PARP inhibitor biomarkers market is experiencing significant growth, driven by the increasing prevalence of cancer and the rising demand for targeted therapies. PARP inhibitors are a class of drugs that have shown promise in treating cancers with specific genetic mutations, particularly in breast and ovarian cancers. As the understanding of cancer biology advances, the identification and validation of biomarkers that predict response to PARP inhibitors are becoming critical for personalized medicine. This market is expected to expand as researchers and clinicians seek to optimize treatment strategies and improve patient outcomes.

Moreover, advancements in biomarker discovery technologies are propelling innovation within the PARP inhibitor biomarkers market. The development of next-generation sequencing, liquid biopsy techniques, and bioinformatics tools is enhancing the ability to identify and validate biomarkers associated with PARP inhibitor efficacy. These innovations not only improve the accuracy of biomarker testing but also facilitate the development of companion diagnostics that can guide treatment decisions. As research continues to explore new biomarkers and their clinical applications, the market is likely to expand further, driven by the promise of improved precision in cancer therapy.

Additionally, the growing emphasis on personalized medicine and patient-centric approaches is shaping the PARP inhibitor biomarkers landscape. As healthcare providers increasingly prioritize tailored treatment plans that consider individual patient characteristics, the demand for reliable biomarkers that can inform treatment decisions is likely to increase. This trend is particularly relevant in the context of clinical trials and drug development, where biomarker-driven strategies can enhance the efficiency and success rates of new therapies. As the PARP inhibitor biomarkers market continues to evolve, the combination of technological advancements, a focus on personalized medicine, and the need for effective cancer treatments will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product

By Services

By Application

TABLE OF CONTENTS

1. PREFACE

2. EXECUTIVE SUMMARY

3. PARP INHIBITOR BIOMARKERS INDUSTRY ANALYSIS

4. VALUE CHAIN ANALYSIS

5. GLOBAL PARP INHIBITOR BIOMARKERS MARKET ANALYSIS BY PRODUCT

6. GLOBAL PARP INHIBITOR BIOMARKERS MARKET ANALYSIS BY SERVICES

7. GLOBAL PARP INHIBITOR BIOMARKERS MARKET ANALYSIS BY APPLICATION

8. GLOBAL PARP INHIBITOR BIOMARKERS MARKET ANALYSIS BY GEOGRAPHY

9. COMPETITIVE LANDSCAPE OF THE PARP INHIBITOR BIOMARKERS COMPANIES

10. COMPANY PROFILES OF PARP INHIBITOR BIOMARKERS INDUSTRY

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â